Liquid biopsy testing specialists. Ultrasensitive cancer diagnosis and monitoring to 0.001% variant frequency.

Biotechnology

Health Care

Life Sciences

SAGA Diagnostics

SAGA Diagnostics' headquarters in Lund, Sweden

Peter Collins

Rocco Crescenzo

Mark Landers

Brian Dow

Lao Saal

Anthony George

Annina E. Hube

The Clinical and Laboratory Operations team at SAGA Diagnostics manages and oversees the execution of liquid biopsy testing for ultrasensitive cancer diagnosis and monitoring. They ensure the precision and reliability of diagnostic results through advanced molecular techniques and rigorous quality assurance, while also driving innovation and efficiency in lab processes.

Clinical And Laboratory Operations

The Leadership Team at SAGA Diagnostics is responsible for setting strategic direction, overseeing clinical operations and development, and driving innovation in liquid biopsy testing for ultrasensitive cancer diagnosis and monitoring. This team ensures the company's mission to achieve 0.001% variant frequency detection is met, while spearheading business growth and maintaining clinical excellence.

Leadership Team

The Clinical and Research team at SAGA Diagnostics specializes in developing and validating ultrasensitive liquid biopsy tests for cancer diagnosis and monitoring at variant frequencies as low as 0.001%. They drive clinical development, oversee laboratory and quality assurance, conduct cutting-edge research, and employ advanced bioinformatics to ensure accurate and reliable results.

SAGA Diagnostics

Org chart

Teams

Clinical And Laboratory Operations

Leadership Team

Clinical and Research

Offices

SAGA Diagnostics

Org chart

Teams

Clinical And Laboratory Operations

Leadership Team

Clinical and Research

Offices

Related companies